September #127 : Magnum PIs: Protease inhibitor bulletin

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Back to School

The Money Pit

Retro Virus


Old School

“C” Ya In Bed

Kick in the Butt

Dear Dairy

Magnum PIs: Protease inhibitor bulletin

Code Blueberry

The Porn Identity

Bye George!

Good, Dirty Fun

Deposit Slip

Blood Sport

United We Fall

U.S. Steal

A Capitol Punishment?

The Mourning Show


Hurts So Good

Editor’s Letter-Septmeber 2006

Mailbox-September 2006

Catch of the Month-September 2006

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

September 2006

Magnum PIs: Protease inhibitor bulletin

Prezista and Aptivus are the latest approved members of the protease inhibitor (PI) HIV med class. Like other PIs, these cut viral loads by preventing immune cells from making more HIV, and they require a Norvir (ritonavir) booster dose. But these two may knock out some HIV that’s grown PI-resistant.

  1. Prezista (darunavir, formerly TMC-114), which won FDA approval in June, controlled HIV with a twice-daily dose, even in those who’ve taken PIs before.
  2. Aptivus (tipranavir) was approved last year for those who’ve taken combos (including PIs) before. But recently, some Aptivus takers developed bleeding in the brain. While researchers locate the cause, Aptivus should be used cautiously by anyone with risk factors for excessive brain bleeding such as high blood pressure or use of blood thinners. Red flags are up, too, for those allergic to sulfa drugs (an Aptivus ingredient). The future of the PI for those new to HIV meds is hazy: In May, a study for treatment newcomers was halted when Aptivus with a 200 mg Norvir booster was found to be liver-unfriendly, while Aptivus plus 100 mg Norvir was ineffective.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Have you ever served in the U.S. military?

Are You Prepared?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.